Monthly Archives: October 2011
A few weeks ago was Mental Illness Awareness Week, which gave me a lot to think about. For the most part, I’ve considered my bipolar disorder to be something essentially private, much like if I had asthma or some other disease. As a result, it didn’t warrant any public revelation, not so much because I was ashamed of it (I’m not), but because I don’t normally discuss any of my other illnesses, so why would I discuss this one? Continue reading
I’ve spent the last several years completing a doctorate in philosophy, and bipolar disorder has been in some ways a hindrance and in some ways a benefit. One way in which bipolar disorder has been a bit of both has been its tendency to push me toward skepticism. Our moods and our thoughts are connected both ways, and instability of moods creates an instability of thoughts. However, instability leads to skepticism for a number of reasons. I’ve both had to fight against this tendency and embrace the aspects of it that are good. Continue reading
This post is long, so I’ve decided to break it into two parts. This is the first part, while the second part is here.
I’ve only really become active in what one might call the mental health community within the last couple of years. Like any movement, the mental health community has its own vocabulary. Since I already had my own vocabulary that I was perfectly happy with, some of those uses struck me as strange, to the point where I don’t even want to use the terms. However, I’m well aware of my linguistic conservativism and that it’s probably a bad habit. Continue reading
In the first part of this blog post, I discussed what the problems were with the term “stigma”. Although I have still some reservations about the limitations of the term and the way that the term is employed, there are still some very good reasons to use the term. In this second half, I will discuss those reasons. Continue reading
This week, Forest Laboratories and Gedeon Richter announced that they have had success in testing cariprazine, an antipsychotic, as a treatment for bipolar disorder. With a number of atypical antipsychotics becoming generic in the next decade, profits will be smaller in a generically flooded market, and less research is likely to be done. As a result, it is always good to see new options available for bipolar people. Moreover, by all accounts, cariprazine did very well, proving itself more effective than placebo and also proving itself well tolerated. Continue reading
In order to put together this site, I need to do a lot of online searches. Most of those searches involve searching for the term “bipolar”. Along with information that I find useful for my daily news or my weekly blog, I also find something of a flotsam of other uses of the term that can be a little surprising. Since I’ve had to spend so much of my time wading through these alternative uses of the term, I figured I was entitled to get some use out of them. So, I’ve collected together these uses that are sometimes interesting, sometimes bizarre and sometimes offensive. Continue reading